Effect of rapid maxillary expansion on glenoid fossa and condylar position in growing patients

ISRCTN ISRCTN77788053
DOI https://doi.org/10.1186/ISRCTN77788053
Secondary identifying numbers MG_002
Submission date
31/10/2017
Registration date
07/11/2017
Last edited
23/11/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Growing children may have dental crowding, crossbite (where the upper teeth fall inside the lower teeth when you bite), breathing problems, and hearing loss, due to insufficient (not enough) growth of the maxillary bone (the bone in the front of the face). Rapid maxillary extension (RME) is an orthodontic procedure that uses a device implanted in the palate to expand the maxillary bone, ultimately resulting in increasing its diameter, and eventually correcting breathing problems, hearing loss, teeth position and crossbite. The aim of this study is to investigate if RME in growing patients will result in radiographic changes at the level of glenoid fossa and nasal cavity width compared to a control group.

Who can participate?
Children aged 8 to 13 years old who have a maxillary skeletal deficiency with a crossbite.

What does the study involve?
Participants are randomly allocated to one of two groups. Those in the first group undergo rapid maxillary extension (RME) implanted. Those in the second group have no device implanted. Participants are followed up three weeks after their first visit where the RME is removed. Participants are evaluated and have x-rays. Participants are then followed up again at six months for a clinical examination and have their mouth imaging. Participants are assessed for their improvements in their crossbite.

What are the possible benefits and risks of participating?
Participants in the treatment group may benefit from enhancing nasal breathing, and eventually avoiding vital problems such as obstructive sleep apnea, preventing problems of the temporo-mandibular joints, avoiding skeletal and dental malocclusions that may require invasive orthognathic surgery later in adulthood and facilitating hearing by relieving constriction at the level of the Eustachian tubes. There are no foreseeable medical risks with taking part in participating.

Where is the study run from?
Lebanese University School of Dentistry (Lebanon)

When is the study starting and how long is it expected to run for?
March 2016 to June 2018

Who is funding the study?
Centre National de Recherche Scientifique, Lebanon (CNRS) (Lebanon)

Who is the main contact?
Dr Mona Sayegh-Ghoussoub
mghoussoub@ul.edu.lb

Contact information

Dr Mona Sayegh-Ghoussoub
Scientific

Lebanese University
School of Dentistry
Department of Orthodontics
Hadath- Lebanon
Beirut
-
Lebanon

Phone +961 3559095
Email mghoussoub@ul.edu.lb

Study information

Study designOpen two-arm parallel group controlled prospective clinical trial
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Other
Study typeTreatment
Participant information sheet No participant information sheet available
Scientific titleEffect of rapid Maxillary Expansion on glenoid fossa and condyle-fossa relationship in Growing Patients: Study protocol for a controlled clinical trial
Study acronymMEGP
Study objectivesIn growing patients with significant maxillary skeletal deficiency in the transverse dimension with bilateral crossbite, rapid maxillary extension increases interglenoid fossa distance, condyle fossa relationship, and nasal width, compared to a control group.
Ethics approval(s)Research Ethics Committee of Dental School, Lebanese University, 11/08/2015, ref: 31.04.2015
Health condition(s) or problem(s) studiedGrowing subjects, aged 8 to 13 years presenting a transverse maxillary skeletal deficiency, with bilateral crossbite involving one or more posterior teeth
InterventionAt baseline, all the patients undergo clinical examination, plaster study model casts and maxillary low-dose 3D CBCT (Cone-beam computed tomography) with an iCat® machine (Imaging Sciences International, Hatfield, Pa). Patients allocated to the treatment group will undergo rapid maxillary extension (RME) [T0], while patients in the control group will have no device implanted.

Study group: Participants included in this group undergo an RME with an expansion device (Hyrax®,Dentaurum, Ispringen, Germany). The opening of the intermaxillary suture will be checked clinically by the occurrence of an interincisal diastema and radiologically as radiolucency appearing at the same region on an occlusal X-ray.

Control group: Participants presenting the same characteristics as the study group but asking to postpone the RME, are included in this group.

A follow-up visit is scheduled three weeks after the first visit (T0), termed (T1), where patients in the RME group undergo device removal. All the patients from both groups has a clinical examination and on occlusal X Ray.

A follow-up visit is scheduled six months weeks after T1, termed (T2), where all the patients undergo a clinical examination and a repeat maxillary low-dose 3D CBCT.

Thus, participants are seen at three predefined visits.
Intervention typeDevice
Pharmaceutical study type(s)
Phase
Drug / device / biological / vaccine name(s)
Primary outcome measureInterglenoid fossa distance is measured using specific software (ITK-SNAP, IMAGINE, CMF) at baseline and 6-month visit.

All the outcomes are radiological. Radiological data acquired with CBCT obtained at baseline and 6 months will be saved as DICOM files. 3-dimensional surface models of the anatomic structures will be built using specific software (ITK-SNAP; open-source software, www.itksnap.org; IMAGINE, open-source software, http://www.ia.unc.edu/dev/download/imagine , Cranio-Maxillo-Facial (CMF) application software, M. E. Müller Institute for Surgical Technology and Biomechanics, University of Bern, http://co-me.ch ).
Secondary outcome measures1. Condyle fossa relationships are measured using specific software (ITK-SNAP, IMAGINE, CMF) at baseline and 6-month visit
2. 3D condylar angles are measured using specific software (ITK-SNAP, IMAGINE, CMF) at baseline and 6-month visit
3. Nasal width is measured using specific software (ITK-SNAP, IMAGINE, CMF) at baseline and 6-month visit
Overall study start date01/03/2016
Completion date01/06/2018

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit8 Years
Upper age limit13 Years
SexBoth
Target number of participants40
Key inclusion criteria1. Male or female growing subject
2. Aged 8 to 13 years
3. Presence of a transverse maxillary skeletal deficiency, with bilateral crossbite involving one or more posterior teeth (bicuspids or molars) assessed by a clinical examination
4. Presence of sufficient crown length (around 3-4mms) to provide the necessary anchorage for the RME appliance selected for the study
5. Presence of a deep palatal vault
6. Dental crowding at the start of treatment
Key exclusion criteria1. Craniofacial syndromes (such as craniosynostosis, Apert-Crouzon, Treacher-Collins, orofacial clefting, etc.)
2. Missing maxillary posterior permanent teeth (first molars)
3. Concomitant periodontal disease
4. Previous orthodontic treatment
Date of first enrolment01/09/2016
Date of final enrolment01/12/2017

Locations

Countries of recruitment

  • Lebanon

Study participating centre

Lebanese University School of Dentistry
Department of Orthodontics
Lebanese University School of Dentistry
Hadath
Beirut
-
Lebanon

Sponsor information

Lebanese University
University/education

School of Dentistry
Department of Orthodontics
Lebanese University
Beirut
-
Lebanon

Website www.ul.edu.lb
ROR logo "ROR" https://ror.org/05x6qnc69

Funders

Funder type

Research organisation

Centre National de Recherche Scientifique, Lebanon (CNRS)

No information available

Lebanese University

No information available

Results and Publications

Intention to publish date15/07/2018
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
Publication and dissemination planPlanned publication in a high-impact peer reviewed journal.
IPD sharing planThe current data sharing plans for the current study are unknown and will be made available at a later date.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 01/03/2018 23/11/2020 Yes No

Editorial Notes

23/11/2020: Publication reference added.
22/01/2018: Internal review.